Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
131.19 | -10.02% | 3.18% | 332,278.86 | 2.35% | -19.03% |
|
LSE:AZN
AstraZeneca PLC
|
121.10 | 18.89% | 41.61% | 187,733.46 | 2.01% | 15.98% |
|
SWX:ROG
Roche Holding
|
237.10 | 25.34% | 40.63% | 191,277.25 | 4.05% | 0.43% |
|
SWX:NOVN
Novartis
|
93.37 | 8.15% | 21.52% | 190,512.74 | 3.53% | 4.67% |
|
ENXTPA:SAN
Sanofi
|
89.17 | 19.33% | 38.3% | 111,472.92 | 4.22% | 8.19% |
|
LSE:GSK
GSK
|
17.75 | 7.44% | 23.26% | 72,385.16 | 3.27% | 0.79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61.74% | 72.08% | 89,253.22 | 5.45% | 13.54% |
|
ENXTPA:IPN
Ipsen
|
120.80 | -14.58% | -6.56% | 9,878.9 | 0.99% | 9.14% |
|
ENXTBR:SOLB
Solvay
|
34.07 | 17.96% | 41.12% | 3,611.22 | 7.13% | 9.75% |
|
NSEI:PFIZER
Pfizer
|
4400.55 | 17.47% | 24.52% | 201,315.18 | 0.8% | 6.5% |
|
HOSE:DHG
DHG Pharmaceutical Joint Stock
|
115600.00 | 24.25% | 39.02% | 14,918,126.7 | 3.03% | 0% |
|
ASX:MYX
Mayne Pharma Group
|
6.37 | -,102.84% | -,101.6% | 565.6 | 0% | 0% |
|
UNQ-VNM:PME
Pymepharco Joint Stock
|
80200.00 | -7.78% | 12.99% | 6,015,932.33 | 2.49% | -0.94% |
|
HOSE:IMP
Imexpharm
|
66600.00 | 15.58% | 0% | 4,557,302.65 | 1.43% | 0% |
|
HOSE:DBD
Binh Dinh Pharmaceutical and Medical
Equipment Joint Stock |
52700.00 | 31.14% | 0% | 3,974,188.47 | 3.8% | 21.39% |
|
HOSE:DCL
Cuu Long Pharmaceutical Joint Stock
|
30100.00 | 0% | 0% | 1,972,107.81 | 0% | 0% |
|
HOSE:DMC
Domesco Medical Import - Export
Joint-Stock |
56200.00 | 0% | 0% | 1,739,846 | 4.2% | 7.48% |
|
HOSE:OPC
OPC Pharmaceutical Joint Stock
|
23450.00 | 0% | 0% | 1,614,082.48 | 6.4% | 0% |
|
HNX:LDP
Lamdong Pharmaceutical Joint Stock
|
23000.00 | 0% | 0% | 284,550.22 | 0% | 0% |
|
HOSE:DBT
Ben Tre Pharmaceutical Joint Stock
|
12450.00 | 0% | 0% | 207,333.56 | 0% | 0% |
